日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble gp130 inhibits Th17 polarization in neutrophilic asthma by blocking IL-6 trans-signaling in dendritic cells

可溶性gp130通过阻断树突状细胞中的IL-6反式信号传导来抑制中性粒细胞性哮喘中的Th17极化。

Zhu, Suhua; Yao, Yun; Lv, Tangfeng; Yao, Feng; Xu, Jing; Zhang, Ang; Zhang, Fang

Anti-Inflammatory Mechanisms of Selenium Nanosheets in Ulcerative Colitis: Protein Corona, GP130 Interaction, and Transcriptomic Profile.

硒纳米片在溃疡性结肠炎中的抗炎机制:蛋白质冠、GP130 相互作用和转录组学特征。

Shen Dingyi, Gong Li, Yang Wei, Luo Jiaqi, Jin Zhen, Tang Youzhi

Interleukin-35 inhibits NETs to ameliorate Th17/Treg immune imbalance during the exacerbation of cigarette smoke exposed-asthma via gp130/STAT3/ferroptosis axis

白细胞介素-35通过gp130/STAT3/铁死亡轴抑制NETs,从而改善吸烟诱发哮喘急性发作期间的Th17/Treg免疫失衡。

Peizhi Tao ,Beiting Su ,Xueyan Mao ,Yusen Lin ,Li Zheng ,Xiaoling Zou ,Hailing Yang ,Jing Liu ,Hongtao Li

Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling

更正:雷洛昔芬通过干扰ERβ和IL-6/gp130/STAT3信号通路抑制胰腺腺癌生长

Pozios, Ioannis; Seel, Nina N; Hering, Nina A; Hartmann, Lisa; Liu, Verena; Camaj, Peter; Müller, Mario H; Lee, Lucas D; Bruns, Christiane J; Kreis, Martin E; Seeliger, Hendrik

An engineered palivizumab IgG2 subclass for synthetic gp130 and fas-mediated signaling

一种用于合成gp130和fas介导信号传导的工程化帕利珠单抗IgG2亚类

Christoph Wittich ,Julia Ettich ,Marcel Hertell ,Biswadeep Ghosh Roy ,Haifeng C Xu ,Doreen M Floss ,Philipp A Lang ,Jürgen Scheller

Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation

定义了一条调控 Th17 分化的新型 DYRK1A-gp130/IL-6R-pSTAT 轴

Malueg, Matthew; Moo, Keagan G; Arnett, Azlann; Edwards, Thomas H; Ruskin, Susan L; Lambert, Katharina; Subramanyam, Aditi; Dufort, Matthew J; Gersuk, Vivian H; Partridge, Rebecca; Buckner, Jane H; Khor, Bernard

IL-6/gp130 signaling in CD4(+) T cells drives the pathogenesis of pulmonary hypertension

CD4(+) T细胞中的IL-6/gp130信号通路驱动肺动脉高压的发病机制

Ishibashi, Tomohiko; Inagaki, Tadakatsu; Okazawa, Makoto; Yamagishi, Akiko; Ohta-Ogo, Keiko; Asano, Ryotaro; Masaki, Takeshi; Kotani, Yui; Ding, Xin; Chikaishi-Kirino, Tomomi; Maedera, Noriko; Shirai, Manabu; Hatakeyama, Kinta; Kubota, Yoshiaki; Kishimoto, Tadamitsu; Nakaoka, Yoshikazu

Pharmacological inactivation of a non-canonical gp130 signaling arm attenuates chronic systemic inflammation and multimorbidity induced by a high-fat diet

通过药物手段抑制非经典gp130信号通路可减轻高脂饮食引起的慢性全身炎症和多种疾病。

Youngjoo Lee ,Jade Tassey ,Arijita Sarkar ,Jonathan N Levi ,Siyoung Lee ,Nancy Q Liu ,Andrew C Drake ,Falisha Nguyen ,Jenny Magallanes ,Una Stevic ,Jinxiu Lu ,Dawei Ge ,Hanhan Tang ,Tadiwanashe Mkaratigwa ,Jichen Yang ,Fangzhou Bian ,Ruzanna Shkhyan ,Michael A Bonaguidi ,Denis Evseenko

Dynamic Soluble IL-6R/Soluble gp130 Ratio as a Potential Indicator for the Prostate Malignancy Phenotype-A Multicenter Case-Control Study

动态可溶性IL-6R/可溶性gp130比值作为前列腺恶性表型的潜在指标——一项多中心病例对照研究

Ene, Cosmin-Victor; Geavlete, Bogdan; Mares, Cristian; Nicolae, Ilinca; Ene, Corina Daniela

Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis

抑制gp130受体内的某种信号传导模式可增强组织再生并减轻骨关节炎

Shkhyan, Ruzanna; Flynn, Candace; Lamoure, Emma; Sarkar, Arijita; Van Handel, Benjamin; Li, Jinxiu; York, Jesse; Banks, Nicholas; Van der Horst, Robert; Liu, Nancy Q; Lee, Siyoung; Bajaj, Paul; Vadivel, Kanagasabai; Harn, Hans I-Chen; Tassey, Jade; Lozito, Thomas; Lieberman, Jay R; Chuong, Cheng-Ming; Hurtig, Mark S; Evseenko, Denis